Connect with us

Health

Vir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells – GlobeNewswire

– Growing body of evidence suggests monoclonal antibodies that target a conserved epitope have the potential to be highly effective against SARS-CoV-2…

Published

on

Growing body of evidence suggests monoclonal antibodies that target a conserved epitope have the potential to be highly effective against SARS-CoV-2 and associated known mutations
Newly identified cell surface proteins play a role in SARS-CoV-2 infection and determine how certain classes of antibodies work
SAN FRANCISCO, April 08, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the publication of new preclinical research highlighting novel mechanisms by which SARS-CoV-2…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Moderna Covid vaccine efficacy falls slightly to 90% in US trial – Yahoo News Australia
Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries – The Lancet